公开(公告)号：EP4442832A2

公开(公告)日：2024-10-09

申请号：EP24178591.4

申请日：2019-11-04

Applicant: MarvelBiome, Inc.

Inventor： JAYAMANI, Elamparithi ,  GOVINDAN, Jothi Amaranath ,  CHATTER, Priti H.

IPC: C12P7/22

CPC classification number: A23L19/00 ,  A23L29/06 ,  C12N9/18 ,  C12N9/88 ,  C12Y301/0102 ,  C12Y401/01059 ,  A23L33/10 ,  A23L33/105 ,  A23K20/189 ,  A23K20/111 ,  C12N1/20 ,  A61K38/51 ,  A61K38/465 ,  A61K35/747 ,  A61K31/733 ,  A61K36/185 ,  C12R2001/2520210501 ,  C12N1/205

Abstract: A combination is provided comprising an ellagitannin composition, and an enzymatic composition comprising one or more ellagitannin enzymes, where the one or more ellagitannin enzymes comprise a tannin acyl hydrolase enzyme, a gallate decarboxylase enzyme, or a combination thereof. Methods of making and using combinations disclosed herein are also provided.

公开(公告)号：EP4442265A1

公开(公告)日：2024-10-09

申请号：EP22900323.1

申请日：2022-11-22

Applicant: Inner Mongolia Yili Industrial Group Co., Ltd. ,  Inner Mongolia Dairy Tech Res Institute Co Ltd

Inventor： HUNG, Wei-Lian ,  SHI, Yujie ,  LIU, Wei-Hsien ,  FENG, Haotian ,  LIU, Biao ,  LI, Wei ,  CHEN, Qingshan ,  ZHOU, Mingqiao

IPC: A61K35/745 ,  A61P19/00 ,  A23L33/135

CPC classification number: Y02A50/30 ,  A23C9/16 ,  A23K10/18 ,  A23K10/16 ,  A61P19/10 ,  A61K31/733 ,  A61P19/00 ,  A23C19/06 ,  A61K31/7016 ,  A61K31/702 ,  A23L33/21 ,  A23C9/123 ,  A61P19/08 ,  A61K35/745 ,  A23L2/38 ,  A23C19/032 ,  A23L33/135

Abstract: Disclosed is the use of Bifidobacterium lactis BL-99 in the protection of cartilage. Provided in the present invention is the use of Bifidobacterium lactis in the preparation of a composition for protecting cartilage, wherein the Bifidobacterium lactis is Bifidobacterium lactis with the deposit number of CGMCC No. 15650. The Bifidobacterium lactis can promote the development of cartilage, increase cartilage density, protect cartilage from damage, promote cartilage repair and/or ameliorate cartilage damage, and is beneficial to cartilage health.

公开(公告)号：EP4112064B1

公开(公告)日：2024-07-24

申请号：EP22181397.5

申请日：2022-06-27

IPC: A61K31/733 ,  A61K31/122 ,  A61K31/198 ,  A61K31/593 ,  A61K31/702 ,  A61K31/7048 ,  A61K35/741 ,  A61K36/15 ,  A61K36/185 ,  A61K36/42 ,  A61K8/67 ,  A61K8/9789 ,  A61K8/44 ,  A61K8/49 ,  A61K8/73 ,  A61K8/99 ,  A61P29/00 ,  A23L33/10 ,  A61Q19/00 ,  A61Q19/08 ,  A61K35/744 ,  A61K35/747 ,  A61K36/07 ,  A61K31/366 ,  A61K31/202

CPC classification number: A61K31/733 ,  A61K31/702 ,  A61K35/741 ,  A61K31/198 ,  A61K36/185 ,  A61K36/15 ,  A61K36/42 ,  A61K31/122 ,  A61K31/593 ,  A61K35/747 ,  A61K35/744 ,  A61K31/7048 ,  A61K31/366 ,  A61K31/202 ,  A61K8/9789 ,  A61K8/67 ,  A61Q19/08 ,  A61P29/00 ,  A61K38/40 ,  A61K31/455 ,  A61K31/197 ,  A61K31/4415 ,  A61K36/81 ,  A61K31/375 ,  A61K33/30 ,  A61K31/519 ,  A61K33/04 ,  A61K36/752 ,  A61K36/45 ,  A61K36/9066 ,  A61K36/80 ,  A61K31/14 ,  A61K36/07 ,  A23L33/135 ,  A23L33/175 ,  A23L33/105 ,  A23L33/15 ,  A23L33/10 ,  A23L33/21 ,  A61K9/0095 ,  A61K8/73 ,  A61K8/442 ,  A61K8/498 ,  A61K2800/592220130101 ,  A61K8/673 ,  A61K8/99 ,  A61K8/676

公开(公告)号：EP4362955A1

公开(公告)日：2024-05-08

申请号：EP22738440.1

申请日：2022-06-27

Applicant: ASC REGENITY Limited

Inventor： GIRI, Shibashish

IPC: A61K31/733 ,  A61K8/00 ,  A61K8/97 ,  A61K8/9789

CPC classification number: A61K31/733 ,  A61K31/702 ,  A61K35/741 ,  A61K31/198 ,  A61K36/185 ,  A61K36/15 ,  A61K36/42 ,  A61K31/122 ,  A61K31/593 ,  A61K35/747 ,  A61K35/744 ,  A61K31/7048 ,  A61K31/366 ,  A61K31/202 ,  A61K8/9789 ,  A61K8/67 ,  A61Q19/08 ,  A61P29/00 ,  A61K38/40 ,  A61K31/455 ,  A61K31/197 ,  A61K31/4415 ,  A61K36/81 ,  A61K31/375 ,  A61K33/30 ,  A61K31/519 ,  A61K33/04 ,  A61K36/752 ,  A61K36/45 ,  A61K36/9066 ,  A61K36/80 ,  A61K31/14 ,  A61K36/07 ,  A23L33/135 ,  A23L33/175 ,  A23L33/105 ,  A23L33/15 ,  A23L33/10 ,  A23L33/21 ,  A61K9/0095 ,  A61K8/73 ,  A61K8/442 ,  A61K8/498 ,  A61K2800/592220130101 ,  A61K8/673 ,  A61K8/99 ,  A61K8/676

公开(公告)号：EP2162020B1

公开(公告)日：2018-10-31

申请号：EP08766799.4

申请日：2008-06-13

Applicant: N.V. Nutricia

Inventor： HOUGEE, Sander ,  VRIESEMA, Adrianus Johannes Maria ,  GARSSEN, Johan ,  KNOL, Jan

IPC: A23L33/135 ,  A23L33/125 ,  A23L33/21 ,  A23L33/22 ,  A61K31/733 ,  A61K35/74 ,  A23L29/30 ,  A61K31/702

CPC classification number: A23L33/40 ,  A23L5/00 ,  A23L29/30 ,  A23L33/115 ,  A23L33/12 ,  A23L33/125 ,  A23L33/135 ,  A23L33/19 ,  A23L33/21 ,  A23L33/22 ,  A23V2002/00 ,  A23Y2300/29 ,  A61K31/702 ,  A61K31/733 ,  A61K35/745 ,  A61K2035/115 ,  A61K2300/00 ,  A23V2200/304 ,  A23V2250/1882 ,  A23V2250/5424 ,  A23V2250/5046 ,  A23V2250/28

Abstract: An infant and/or toddler nutrition comprising non-viable Bifidobacterium breve and a non-digestible oligosaccharide and its use are disclosed.

公开(公告)号：EP3369423A1

公开(公告)日：2018-09-05

申请号：EP17305221.8

申请日：2017-03-01

Applicant: REMINISCIENCES

Inventor： The designation of the inventor has not yet been filed

IPC: A61K31/715 ,  A61K31/733 ,  A61K35/741

CPC classification number: A61K35/741 ,  A61K31/715 ,  A61K31/733

Abstract: The invention relates to a new synbiotic composition comprising a mixture of probiotic and prebiotic ingredients for the prevention and/or treatment of neurodegenerative disorder, in particular Alzheimer's disease. The new synbiotic composition can comprise, in particular, at least one Roseburia species and at least one Verrucomicrobiales species in combination with dietary fibers.

公开(公告)号：EP3294271A1

公开(公告)日：2018-03-21

申请号：EP16725783

申请日：2016-05-11

Applicant: SYLPHAR NV

Inventor： LIST ROBIN

IPC: A61K9/48 ,  A23L33/105 ,  A23P10/30 ,  A61K31/315 ,  A61K31/733 ,  A61K36/45 ,  A61Q11/00

CPC classification number: A61K9/4808 ,  A23L33/105 ,  A23L33/185 ,  A23L33/21 ,  A23P10/30 ,  A61K9/4816 ,  A61K9/4833 ,  A61K31/718 ,  A61K31/733 ,  A61K31/734 ,  A61K33/30 ,  A61K36/185 ,  A61K36/28 ,  A61K36/45 ,  A61K36/61 ,  A61K36/82 ,  A61K45/06 ,  A61Q11/00 ,  A61K2300/00

Abstract: The invention concerns a soft capsule comprising (a) a first soft capsule configured for targeted delivery to the mouth and (b) a second soft capsule configured for targeted delivery to the stomach, wherein the first soft capsule comprises one or more active ingredients capable of blocking adhesion of harmful bacteria to the oral cavity, a metal salt, and a prebiotic fibre, wherein the one or more active ingredients capable of blocking adhesion of harmful bacteria to the oral cavity are selected from the group consisting of cranberry extract, wild blueberry extract, strawberry extract, tea tree oil, and chamomile oil, and wherein the metal salt is a zinc salt; the second soft capsule comprises one or more active ingredients capable of blocking adhesion of harmful bacteria to the stomach and an alginate, wherein the one or more active ingredients capable of blocking adhesion of harmful bacteria to the stomach are selected from the group consisting of cranberry extract, wild blueberry extract, strawberry extract, tea tree oil, chamomile oil, tea extract, neem stick extract, snowdrop extract, seaweed extract, hop bract extract, Galla chinensis extract, avocado, and legume storage proteins; and the second soft capsule is contained in the first soft capsule. The invention further relates to the soft capsules for use in the treatment of halitosis.

公开(公告)号：EP3264898A1

公开(公告)日：2018-01-10

申请号：EP16715881.5

申请日：2016-02-24

Applicant: Trovo´, Stefano

Inventor： Trovo´, Stefano

IPC: A01N63/00 ,  A01P1/00 ,  A01P3/00

CPC classification number: A01N63/00 ,  A61K9/145 ,  A61K31/733 ,  A61K35/744 ,  A61K2035/11 ,  A61K2300/00

Abstract: Composition comprising the association of viable microorganisms of the species Lactobacillus buchneri and viable microorganisms of at least one species selected from the group of: Pediococcus pentosaceus, Lactococcus lactis and Lactobacillus plantarum, and prebiotic agents for the use in the biological control of the well-being of bees, in the prophylaxis and treatment of diseases of the bees caused by the fungus Nosema spp. and for the use in the reduction of the physiological decrease of brood occurring at the end of the summer in the hive.

公开(公告)号：EP3071235B1

公开(公告)日：2017-12-13

申请号：EP16704085.6

申请日：2016-01-13

Applicant: Kaleido Biosciences, Inc.

Inventor： VON MALTZAHN, Geoffrey A. ,  SILVERMAN, Jared ,  YAMANAKA, Yvonne J. ,  MILWID, Jack ,  GEREMIA, John M.

IPC: A61K31/702 ,  A61K31/716 ,  A61K31/733 ,  A61K31/7016 ,  A61K45/06 ,  A61P1/00

CPC classification number: A61K31/702 ,  A23L33/10 ,  A23P10/00 ,  A23V2002/00 ,  A61K31/7004 ,  A61K31/7016 ,  A61K31/716 ,  A61K31/733 ,  A61K35/741 ,  A61K45/06 ,  A61K2035/115 ,  A61P1/00 ,  Y02A50/475 ,  Y02A50/481

Abstract: Preparations of glycan therapeutics, pharmaceutical compositions and medical foods thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same. Also provided are methods of using said glycan therapeutics, e.g. for the modulation of human gastrointestinal microbiota and to treat dysbioses.

公开(公告)号：EP3088008A1

公开(公告)日：2016-11-02

申请号：EP14873568.1

申请日：2014-12-25

Applicant: Nissan Chemical Industries, Ltd.

Inventor： IWAMA, Takehisa ,  HAYASHI, Hisato

IPC: A61L15/16 ,  A61K9/10 ,  A61K9/12 ,  A61K9/70 ,  A61K31/716 ,  A61K31/717 ,  A61K31/718 ,  A61K31/721 ,  A61K31/722 ,  A61K31/732 ,  A61K31/733 ,  A61K47/18 ,  A61K47/32 ,  A61K47/36 ,  A61K47/38 ,  A61K47/40 ,  A61K47/42 ,  A61P7/04 ,  A61P17/02

CPC classification number: A61L26/0023 ,  A61K9/10 ,  A61K9/12 ,  A61K9/143 ,  A61K9/7015 ,  A61K31/716 ,  A61K31/717 ,  A61K31/722 ,  A61K31/724 ,  A61K31/732 ,  A61K31/733 ,  A61K31/736 ,  A61K31/765 ,  A61L26/0066 ,  A61L26/0076 ,  A61L2300/23 ,  A61L2300/418 ,  A61L2400/04 ,  C08L1/00

Abstract: There is provided a novel hemostatic material (aqueous dispersion) that can be applied by a simple method of application in the form of a liquid or a spray mist to a bleeding wound surface, exhibits an excellent solidifying action on all of plasma, serum, and blood, and achieves a hemostatic effect quickly and easily. An aqueous dispersion comprising insoluble polysaccharides having an average fiber diameter (D) of 0.001 to 100 µm and a ratio (L/D) of an average fiber length (L) to an average fiber diameter (D) of 5 to 500, characterized in that the aqueous dispersion causes plasma, serum, or blood to solidify under contact with plasma, serum, or blood.

Abstract translation: 提供了一种新颖的止血材料（水性分散体），其可以通过简单的施用方式以液体或喷雾的形式施用于出血的伤口表面，对血浆，血清和血清全部呈现出优异的凝固作用 血液，快速，轻松地达到止血效果。 一种水分散体，其包含平均纤维直径（D）为0.001〜100μm，平均纤维长度（L）与平均纤维直径（D）的比率（L / D）为5〜500的不溶性多糖，其特征在于， 水分散体使血浆，血清或血液在血浆，血清或血液接触下固化。